
Climb Bio, Inc., is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. The Companys lead product candidate, budoprutug, is an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has potential to treat a broad range of B-cel... Climb Bio, Inc., is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. The Companys lead product candidate, budoprutug, is an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has potential to treat a broad range of B-cell mediated diseases. 詳細を表示
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.13 | -8.90410958904 | 1.46 | 1.5138 | 1.2 | 274525 | 1.33093262 | CS |
4 | -0.26 | -16.3522012579 | 1.59 | 1.61 | 1.2 | 357236 | 1.43033141 | CS |
12 | -0.6 | -31.0880829016 | 1.93 | 2.36 | 1.2 | 462771 | 1.78139325 | CS |
26 | -3.7 | -73.5586481113 | 5.03 | 5.86 | 1.2 | 376617 | 2.61203852 | CS |
52 | -3.7 | -73.5586481113 | 5.03 | 5.86 | 1.2 | 376617 | 2.61203852 | CS |
156 | -3.7 | -73.5586481113 | 5.03 | 5.86 | 1.2 | 376617 | 2.61203852 | CS |
260 | -3.7 | -73.5586481113 | 5.03 | 5.86 | 1.2 | 376617 | 2.61203852 | CS |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約